Pirfenex 801 mg, an advanced formulation with an optimized dosage of Pirfenidone, meticulously crafted to address the complexities of severe idiopathic pulmonary fibrosis (IPF). With its strong 801 mg strength, Pirfenex offers a promising solution for patients who require more intensive therapy to manage their IPF effectively. Choose Pirfenex 801 mg for a compelling and proactive approach to fighting IPF and improving your quality of life.
Pirfenidone is used in the treatment of Idiopathic Pulmonary Fibrosis. It Reduces Lungs fibrosis through downregulation of the production of growth factors and procollagens I and II.
Pirfenidone is indicated for the treatment of mild-to-moderate idiopathic pulmonary fibrosis. Pirfenidone axunio is a medicine used to treat adults with mild to moderate idiopathic pulmonary fibrosis (IPF). IPF is a long-term disease in which fibrous scar tissue continuously forms in the lungs, causing persistent cough, frequent lung infections, and severe shortness of breath.
IPF is a chronic fibrotic and inflammatory lung disease where the lung tissues become swollen and scarred over time due to the synthesis and release of certain chemicals causing difficulty in breathing. Pirfenidone is an anti-fibrotic and anti-inflammatory agent and belongs to a class of medications called pyridones. Pirfenidone medication relieves conditions of idiopathic pulmonary fibrosis by reducing fibroblast growth thereby relieving swelling and inflammation of the lungs.